Fig. 1From: The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based studyFlowchart, patient population. Study flowchart identifying the n = 171 patients constituting the study cohort among 733 consecutive patients diagnosed with gastric adenocarcinoma in Central Norway 2007–2016 (NAC, neoadjuvant chemotherapy)Back to article page